Christopher Liong, Chairman   Chris is Director of Research at Suffolk Capital Management, a New York-based investment firm with over $3 billion under management. He joined Suffolk Capital Management in 1996 as a Research Analyst covering the technology and telecom sectors. Mr. Liong became the firm’s first Director of Research in 1999, leading the firm’s analysts in applying Suffolk Capital Management’s valuation methodology. Two years later, Mr. Liong began to assist the Chief Investment Officer in managing the Mid/Large Cap Core Equity Fund. In 2002, Mr. Liong began the firm’s Large Cap Growth Fund. Mr. Liong received his B.S. in Material Science from Cornell University.

Christopher Liong, Chairman

Chris is Director of Research at Suffolk Capital Management, a New York-based investment firm with over $3 billion under management. He joined Suffolk Capital Management in 1996 as a Research Analyst covering the technology and telecom sectors. Mr. Liong became the firm’s first Director of Research in 1999, leading the firm’s analysts in applying Suffolk Capital Management’s valuation methodology. Two years later, Mr. Liong began to assist the Chief Investment Officer in managing the Mid/Large Cap Core Equity Fund. In 2002, Mr. Liong began the firm’s Large Cap Growth Fund. Mr. Liong received his B.S. in Material Science from Cornell University.

  Jon Liong, Managing Director   Jon has been organizing life sciences / healthcare events for over 17 years and focused on China's healthcare conferences.  He played an integral role in launching the China industry's first R&D conference (Impact China 2005), first clinical development conference (ChinaTrials 2008), first medical affairs conference (China Medical Affairs Summit 2012) and first investor-focused event (China Healthcare Investment Conference CHIC 2010).

Jon Liong, Managing Director

Jon has been organizing life sciences / healthcare events for over 17 years and focused on China's healthcare conferences.  He played an integral role in launching the China industry's first R&D conference (Impact China 2005), first clinical development conference (ChinaTrials 2008), first medical affairs conference (China Medical Affairs Summit 2012) and first investor-focused event (China Healthcare Investment Conference CHIC 2010).

  Eric Lu, Vice President, Operations    

Eric Lu, Vice President, Operations

 

 
  Hidy Fu, Director    

Hidy Fu, Director

 

  Louisa Chen, Director    

Louisa Chen, Director